Efficacy and safety of neoadjuvant therapy for triple-negative breast cancer: a Bayesian network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of neoadjuvant therapy for triple-negative breast cancer: a Bayesian network meta-analysis

Published:2022-09-20 Issue:10 Volume:22 Page:1141-1151
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Yu Yushuai¹,Zhang Jie¹²³,Lin Yuxiang¹²³,Kang Shaohong¹,Lv Xinyin¹,Song Chuangui¹²³

Affiliation:

1. Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China

2. Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China

3. Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, China

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2125381

Reference71 articles.

1. The epidemiology of triple-negative breast cancer, including race

2. Epidemiology of basal-like breast cancer

3. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

4. Breast Cancer Treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comments on “Detecting the research trends and evolution of energy resilience: a bibliometric analysis” by Yu et al. (https://doi.org/10.1007/s11356-022-23768-1);Environmental Science and Pollution Research;2023-03-08

2. Fluoride accumulation characteristics in a northern China apple orchard that has had long-term phosphate fertilization;Science of The Total Environment;2023-02

3. Research on Intelligent Verification Technology of Bus Protection SCD File in Intelligent Substation Reconstruction and Expansion Project Based on Convolutional Neural Network;2022 IEEE/IAS Industrial and Commercial Power System Asia (I&CPS Asia);2022-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3